Nelson M - Search Results

1

Telaprevir-containing triple therapy in acute HCV coinfection: The CHAT Study.

Boesecke C, Singh GKJ, Scholten SH, Lutz T, Baumgarten A, Schneeweiss SM, Trein A, Rausch M, Ingiliz P, Rockstroh JK, Nelson M; CHAT study group. Boesecke C, et al. Among authors: nelson m. Antivir Ther. 2017;22(7):619-623. doi: 10.3851/IMP3143. Epub 2017 Feb 27. Antivir Ther. 2017. PMID: 28240597 Clinical Trial.

2

An open-label, randomized comparative pilot study of a single-class quadruple therapy regimen versus a 2-class triple therapy regimen for individuals initiating antiretroviral therapy.

Moyle G, Higgs C, Teague A, Mandalia S, Nelson M, Johnson M, Fisher M, Gazzard B. Moyle G, et al. Among authors: nelson m. Antivir Ther. 2006;11(1):73-8. Antivir Ther. 2006. PMID: 16518962 Clinical Trial.

3

Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.

Schmutz G, Nelson M, Lutz T, Sheldon J, Bruno R, von Boemmel F, Hoffmann C, Rockstroh J, Stoehr A, Wolf E, Soriano V, Berger F, Berg T, Carlebach A, Schwarze-Zander C, Schürmann D, Jaeger H, Mauss S. Schmutz G, et al. Among authors: nelson m. AIDS. 2006 Oct 3;20(15):1951-4. doi: 10.1097/01.aids.0000247116.89455.5d. AIDS. 2006. PMID: 16988516 Clinical Trial.

4

Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients.

Waters LJ, Moyle G, Bonora S, D'Avolio A, Else L, Mandalia S, Pozniak A, Nelson M, Gazzard B, Back D, Boffito M. Waters LJ, et al. Among authors: nelson m. Antivir Ther. 2007;12(5):825-30. Antivir Ther. 2007. PMID: 17713166 Clinical Trial.

5

HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.

Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P. Steel A, et al. Among authors: nelson m. Antivir Ther. 2007;12(6):971-5. Antivir Ther. 2007. PMID: 17926652

6

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E; MOTIVATE 1 and MOTIVATE 2 Study Teams. Fätkenheuer G, et al. Among authors: nelson m. N Engl J Med. 2008 Oct 2;359(14):1442-55. doi: 10.1056/NEJMoa0803154. N Engl J Med. 2008. PMID: 18832245 Free article.

7

Acute hepatitis C in HIV-positive individuals.

Low E, Vogel M, Rockstroh J, Nelson M. Low E, et al. Among authors: nelson m. AIDS Rev. 2008 Oct-Dec;10(4):245-53. AIDS Rev. 2008. PMID: 19092980 Review.

8

Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges?

Vogel M, Page E, Nelson M, Rockstroh JK. Vogel M, et al. Among authors: nelson m. J HIV Ther. 2009 Mar;14(1):8-12. J HIV Ther. 2009. PMID: 19731559 Review. No abstract available.

9

HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?

Vogel M, Nelson M. Vogel M, et al. Among authors: nelson m. Eur J Med Res. 2009 Nov 24;14 Suppl 3(Suppl 3):36-42. doi: 10.1186/2047-783x-14-s3-36. Eur J Med Res. 2009. PMID: 19959415 Free PMC article. Review.

10

Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc.

Armstrong-James D, Stebbing J, Scourfield A, Smit E, Ferns B, Pillay D, Nelson M. Armstrong-James D, et al. Among authors: nelson m. Antiviral Res. 2010 May;86(2):224-6. doi: 10.1016/j.antiviral.2010.02.324. Epub 2010 Mar 6. Antiviral Res. 2010. PMID: 20211653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,492 results

Search Page

Filters